Singh; Juswinder
Patent Applications and Registrations
Patent applications and USPTO patent grants for Singh; Juswinder.The latest application filed is for "heterocyclic compounds and uses thereof".
Company Profile
17.74.85
- Singh; Juswinder - Southborough MA
- Singh; Juswinder - Ashland MA
- Singh; Juswinder - Ashand MA
- Singh; Juswinder - Malden MA
Patent Activity
| Patent | Date |
|---|---|
| Heterocyclic Compounds And Uses Thereof App 20220218704 - Lee; Kwangho ; et al. | 2022-07-14 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 11,351,168 - Singh , et al. June 7, 2 | 2022-06-07 |
| MK2 inhibitors and uses thereof Grant 11,098,061 - Alexander , et al. August 24, 2 | 2021-08-24 |
| Heterocyclic compounds and uses thereof Grant 11,096,942 - Lee , et al. August 24, 2 | 2021-08-24 |
| Mk2 Inhibitors And Uses Thereof App 20210053984 - Alexander; Matthew David ; et al. | 2021-02-25 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 10,828,300 - Singh , et al. November 10, 2 | 2020-11-10 |
| Heteroaryl compounds and uses thereof Grant 10,774,052 - D'Agostino , et al. September 15, 2 | 2020-09-15 |
| Heterocyclic Compounds And Uses Thereof App 20200276194 - Lee; Kwangho ; et al. | 2020-09-03 |
| Protein kinase conjugates and inhibitors Grant 10,662,195 - Singh , et al. | 2020-05-26 |
| Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,618,902 - D'Agostino , et al. | 2020-04-14 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,596,172 - Singh , et al. | 2020-03-24 |
| MK2 inhibitors and uses thereof Grant 10,577,380 - Alexander , et al. | 2020-03-03 |
| Mk2 Inhibitors And Uses Thereof App 20190375762 - Alexander; Matthew David ; et al. | 2019-12-12 |
| Heteroaryl Compounds And Uses Thereof App 20190375719 - D'Agostino; Laura Akullian ; et al. | 2019-12-12 |
| Heterocyclic compounds and uses thereof Grant 10,434,101 - Lee , et al. O | 2019-10-08 |
| Heteroaryl Compounds And Uses Thereof App 20190218220 - D'Agostino; Laura Akullian ; et al. | 2019-07-18 |
| Heteroaryl Compounds And Uses Thereof App 20190192512 - Singh; Juswinder ; et al. | 2019-06-27 |
| Mk2 Inhibitors And Uses Thereof App 20190135835 - Alexander; Matthew David ; et al. | 2019-05-09 |
| Heteroaryl Compounds And Uses Thereof App 20190117650 - Singh; Juswinder ; et al. | 2019-04-25 |
| MK2 inhibitors and uses thereof Grant 10,253,040 - Alexander , et al. | 2019-04-09 |
| Heteroaryl compounds and uses thereof Grant 10,189,794 - D'Agostino , et al. Ja | 2019-01-29 |
| Heterocyclic Compounds And Uses Thereof App 20180353508 - Lee; Kwangho ; et al. | 2018-12-13 |
| MK2 inhibitors and uses thereof Grant 10,138,256 - Alexander , et al. Nov | 2018-11-27 |
| Heteroaryl compounds and uses thereof Grant 10,081,606 - Lee , et al. September 25, 2 | 2018-09-25 |
| Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,065,966 - D'Agostino , et al. September 4, 2 | 2018-09-04 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,010,548 - Singh , et al. July 3, 2 | 2018-07-03 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,987,276 - Singh , et al. June 5, 2 | 2018-06-05 |
| ERK inhibitors and uses thereof Grant 9,980,964 - Haq , et al. May 29, 2 | 2018-05-29 |
| Heteroaryl Compounds And Uses Thereof App 20180072687 - Lee; Kwangho ; et al. | 2018-03-15 |
| Heteroaryl Compounds And Uses Thereof App 20180022713 - D'Agostino; Laura Akullian ; et al. | 2018-01-25 |
| Heterocyclic compounds and uses thereof Grant 9,867,824 - Lee , et al. January 16, 2 | 2018-01-16 |
| ERK inhibitors and uses thereof Grant 9,796,700 - Haq , et al. October 24, 2 | 2017-10-24 |
| MK2 inhibitors and uses thereof Grant 9,790,235 - Alexander , et al. October 17, 2 | 2017-10-17 |
| Heteroaryl Compounds And Uses Thereof App 20170267685 - D'Agostino; Laura Akullian ; et al. | 2017-09-21 |
| Heteroaryl compounds and uses thereof Grant 9,765,038 - Lee , et al. September 19, 2 | 2017-09-19 |
| Ligand-Directed Covalent Modification of Protein App 20170218353 - Petter; Russell C. ; et al. | 2017-08-03 |
| Erk Inhibitors And Uses Thereof App 20170210729 - Haq; Nadia ; et al. | 2017-07-27 |
| HCV protease inhibitors and uses thereof Grant 9,694,086 - Petter , et al. July 4, 2 | 2017-07-04 |
| Heteroaryl compounds and uses thereof Grant 9,695,132 - D'Agostino , et al. July 4, 2 | 2017-07-04 |
| Protein Kinase Conjugates and Inhibitors App 20170174691 - Singh; Juswinder ; et al. | 2017-06-22 |
| HCV protease inhibitors and uses thereof Grant 9,676,785 - Niu , et al. June 13, 2 | 2017-06-13 |
| Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors Grant 9,663,524 - D'Agostino , et al. May 30, 2 | 2017-05-30 |
| Erk Inhibitors And Uses Thereof App 20170137406 - Haq; Nadia ; et al. | 2017-05-18 |
| Hcv Protease Inhibitors And Uses Thereof App 20170137463 - Niu; Deqiang ; et al. | 2017-05-18 |
| Mk2 Inhibitors And Uses Thereof App 20170114073 - Alexander; Matthew David ; et al. | 2017-04-27 |
| Heteroaryl Compounds And Uses Thereof App 20170100397 - Singh; Juswinder ; et al. | 2017-04-13 |
| ERK inhibitors and uses thereof Grant 9,561,228 - Haq , et al. February 7, 2 | 2017-02-07 |
| Heterocyclic Compounds and Uses Thereof App 20170027937 - Lee; Kwangho ; et al. | 2017-02-02 |
| Protein kinase conjugates and inhibitors Grant 9,556,426 - Singh , et al. January 31, 2 | 2017-01-31 |
| ERK inhibitors and uses thereof Grant 9,504,686 - Haq , et al. November 29, 2 | 2016-11-29 |
| Hcv Protease Inhibitors And Uses Thereof App 20160326216 - Niu; Deqiang ; et al. | 2016-11-10 |
| Heteroaryl Compounds And Uses Thereof App 20160311780 - Singh; Juswinder ; et al. | 2016-10-27 |
| Heteroaryl Compounds And Uses Thereof App 20160303121 - Singh; Juswinder ; et al. | 2016-10-20 |
| MK2 inhibitors and uses thereof Grant 9,458,175 - Alexander , et al. October 4, 2 | 2016-10-04 |
| Heteroaryl Compounds And Uses Thereof App 20160279127 - Singh; Juswinder ; et al. | 2016-09-29 |
| Hcv Protease Inhibitors And Uses Thereof App 20160243249 - Petter; Russell C. ; et al. | 2016-08-25 |
| HCV protease inhibitors and uses thereof Grant 9,422,333 - Niu , et al. August 23, 2 | 2016-08-23 |
| Hcv Protease Inhibitors And Uses Thereof App 20160235805 - Petter; Russell C. ; et al. | 2016-08-18 |
| 2,4-disubstituted pyrimidines as kinase inhibitors Grant 9,409,921 - Singh , et al. August 9, 2 | 2016-08-09 |
| Heteroaryl Compounds And Uses Thereof App 20160221966 - D'Agostino; Laura Akullian ; et al. | 2016-08-04 |
| 2,4-disubstituted pyrimidine compounds useful as kinase inhibtors Grant 9,375,431 - Lee , et al. June 28, 2 | 2016-06-28 |
| Heteroaryl Compounds And Uses Thereof App 20160130236 - Lee; Kwangho ; et al. | 2016-05-12 |
| Heteroaryl compounds and uses thereof Grant 9,321,786 - D'Agostino , et al. April 26, 2 | 2016-04-26 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,296,737 - Singh , et al. March 29, 2 | 2016-03-29 |
| Substituted pyrimidines as protein kinase inhibitors Grant 9,296,704 - Singh , et al. March 29, 2 | 2016-03-29 |
| Erk Inhibitors And Uses Thereof App 20160082008 - Haq; Nadia ; et al. | 2016-03-24 |
| Mk2 Inhibitors And Uses Thereof App 20160075720 - Alexander; Matthew David ; et al. | 2016-03-17 |
| Heteroaryl Compounds And Uses Thereof App 20160046634 - D'Agostino; Laura Akullian ; et al. | 2016-02-18 |
| Heteroaryl compounds and uses thereof Grant 9,238,629 - Lee , et al. January 19, 2 | 2016-01-19 |
| Erk Inhibitors And Uses Thereof App 20160002176 - Haq; Nadia ; et al. | 2016-01-07 |
| Mk2 Inhibitors And Uses Thereof App 20150376208 - ALEXANDER; Matthew David ; et al. | 2015-12-31 |
| Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,212,181 - Singh , et al. December 15, 2 | 2015-12-15 |
| Heteroaryl Compounds And Uses Thereof App 20150328223 - Singh; Juswinder ; et al. | 2015-11-19 |
| HCV protease inhibitors and uses thereof Grant 9,163,061 - Petter , et al. October 20, 2 | 2015-10-20 |
| ERK inhibitors and uses thereof Grant 9,145,387 - Haq , et al. September 29, 2 | 2015-09-29 |
| Heterocyclic Compounds And Uses Thereof App 20150252019 - Singh; Juswinder ; et al. | 2015-09-10 |
| Heterocyclic Compounds And Uses Thereof App 20150246040 - Lee; Kwangho ; et al. | 2015-09-03 |
| Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20150216865 - Westlin, III; William Frederick ; et al. | 2015-08-06 |
| Heterocyclic compounds and uses thereof Grant 9,067,929 - Singh , et al. June 30, 2 | 2015-06-30 |
| 4,6-disubstituted pyrimidines useful as kinase inhibitors Grant 9,040,541 - Singh , et al. May 26, 2 | 2015-05-26 |
| HCV protease inhibitors and uses thereof Grant 8,980,935 - Niu , et al. March 17, 2 | 2015-03-17 |
| Heterocyclic compounds and uses thereof Grant 8,975,249 - Lee , et al. March 10, 2 | 2015-03-10 |
| Hcv Protease Inhibitors And Uses Thereof App 20150031106 - Niu; Deqiang ; et al. | 2015-01-29 |
| Mutant-selective Egfr Inhibitors And Uses Thereof App 20150025055 - Lee; Kwangho ; et al. | 2015-01-22 |
| Hcv Protease Inhibitors And Uses Thereof App 20140323465 - Niu; Deqiang ; et al. | 2014-10-30 |
| Heteroaryl Compounds And Uses Thereof App 20140303165 - Singh; Juswinder ; et al. | 2014-10-09 |
| Heteroaryl Compounds And Uses Thereof App 20140296233 - D'Agostino; Laura Akullian ; et al. | 2014-10-02 |
| Erk Inhibitors And Uses Thereof App 20140228322 - Haq; Nadia ; et al. | 2014-08-14 |
| Heteroaryl Compounds And Uses Thereof App 20140213574 - Singh; Juswinder ; et al. | 2014-07-31 |
| HCV protease inhibitors and uses thereof Grant 8,778,877 - Niu , et al. July 15, 2 | 2014-07-15 |
| 4,6-diaminopyrimidines useful as kinase inhibitors Grant 8,748,606 - Singh , et al. June 10, 2 | 2014-06-10 |
| HCV protease inhibitors and uses thereof Grant 8,741,837 - Niu , et al. June 3, 2 | 2014-06-03 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,710,222 - Singh , et al. April 29, 2 | 2014-04-29 |
| Heterocyclic Compounds And Uses Thereof App 20140073661 - Singh; Juswinder ; et al. | 2014-03-13 |
| Hcv Protease Inhibitors And Uses Thereof App 20130338062 - Niu; Deqiang ; et al. | 2013-12-19 |
| 2,4-diaminopyrimidines useful as kinase inhibitors Grant 8,609,679 - Singh , et al. December 17, 2 | 2013-12-17 |
| Heterocyclic compounds and uses thereof Grant 8,586,600 - Singh , et al. November 19, 2 | 2013-11-19 |
| HCV protease inhibitors and uses thereof Grant 8,524,760 - Niu , et al. September 3, 2 | 2013-09-03 |
| Heteroaryl Compounds And Uses Thereof App 20130217688 - Singh; Juswinder ; et al. | 2013-08-22 |
| Heteroaryl Compounds And Uses Thereof App 20130165462 - Singh; Juswinder ; et al. | 2013-06-27 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,450,335 - Singh , et al. May 28, 2 | 2013-05-28 |
| Hcv Protease Inhibitors And Uses Thereof App 20130131105 - Petter; Russell C. ; et al. | 2013-05-23 |
| 4,6-disubstituted pyrimidines useful as kinase inhibitors Grant 8,445,498 - Singh , et al. May 21, 2 | 2013-05-21 |
| Heteroaryl Compounds And Uses Thereof App 20130072469 - Singh; Juswinder ; et al. | 2013-03-21 |
| Heteroaryl Compounds And Uses Thereof App 20130065899 - Singh; Juswinder ; et al. | 2013-03-14 |
| Heteroaryl Compounds And Uses Thereof App 20130065879 - Singh; Juswinder ; et al. | 2013-03-14 |
| Heteroaryl Compounds And Uses Thereof App 20130065892 - Singh; Juswinder ; et al. | 2013-03-14 |
| Hcv Protease Inhibitors And Uses Thereof App 20130017991 - Niu; Deqiang ; et al. | 2013-01-17 |
| 2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,338,439 - Singh , et al. December 25, 2 | 2012-12-25 |
| 4,6-disubstitued pyrimidines useful as kinase inhibitors Grant 8,329,901 - Singh , et al. December 11, 2 | 2012-12-11 |
| HCV protease inhibitors and uses thereof Grant 8,309,685 - Petter , et al. November 13, 2 | 2012-11-13 |
| HCV protease inhibitors and uses thereof Grant 8,293,705 - Niu , et al. October 23, 2 | 2012-10-23 |
| Heterocyclic Compounds And Uses Thereof App 20120238593 - Singh; Juswinder ; et al. | 2012-09-20 |
| Heterocyclic compounds and uses thereof Grant 8,242,271 - Singh , et al. August 14, 2 | 2012-08-14 |
| Hcv Protease Inhibitors And Uses Thereof App 20120190614 - Niu; Deqiang ; et al. | 2012-07-26 |
| Heterocyclic Compounds And Uses Thereof App 20120149687 - Lee; Kwangho ; et al. | 2012-06-14 |
| Heteroaryl Compounds And Uses Thereof App 20120149722 - Lee; Kwangho ; et al. | 2012-06-14 |
| HCV protease inhibitors and uses thereof Grant 8,188,137 - Niu , et al. May 29, 2 | 2012-05-29 |
| Ligand-directed Covalent Modification Of Protein App 20110269244 - Petter; Russell C. ; et al. | 2011-11-03 |
| Heteroaryl Compounds And Uses Thereof App 20110230494 - Singh; Juswinder ; et al. | 2011-09-22 |
| Pi3 Kinase Inhibitors And Uses Thereof App 20110230476 - NIU; DEQIANG ; et al. | 2011-09-22 |
| Heteroaryl Compounds And Uses Thereof App 20110224432 - Singh; Juswinder ; et al. | 2011-09-15 |
| 4,6-disubstituted pyrimidines useful as kinase inhibitors Grant 7,989,465 - Singh , et al. August 2, 2 | 2011-08-02 |
| 4,6-disubstitued pyrimidines useful as kinase inhibitors Grant 7,982,036 - Singh , et al. July 19, 2 | 2011-07-19 |
| Protein Kinase Conjugates and Inhibitors App 20110117073 - Singh; Juswinder ; et al. | 2011-05-19 |
| Heteroaryl Compounds And Uses Thereof App 20100249092 - Singh; Juswinder ; et al. | 2010-09-30 |
| Algorithm For Designing Irreversible Inhibitors App 20100185419 - Singh; Juswinder ; et al. | 2010-07-22 |
| Pyrazolopyridines and methods of making and using the same Grant 7,691,865 - Lee , et al. April 6, 2 | 2010-04-06 |
| Hcv Protease Inhibitors And Uses Thereof App 20100069294 - Petter; Russell C. ; et al. | 2010-03-18 |
| Hcv Protease Inhibitors And Uses Thereof App 20100041591 - Niu; Deqiang ; et al. | 2010-02-18 |
| Hcv Protease Inhibitors And Uses Thereof App 20100041674 - Niu; Deqiang ; et al. | 2010-02-18 |
| Heteroaryl Compounds and Uses Thereof App 20100029610 - Singh; Juswinder ; et al. | 2010-02-04 |
| Heteroaryl Compounds And Uses Thereof App 20100016296 - Singh; Juswinder ; et al. | 2010-01-21 |
| Hcv Protease Inhibitors And Uses Thereof App 20090306085 - Petter; Russell C. ; et al. | 2009-12-10 |
| Hcv Protease Inhibitors And Uses Thereof App 20090176858 - Niu; Deqiang ; et al. | 2009-07-09 |
| Heteroaryl Compounds And Uses Thereof App 20090137588 - Singh; Juswinder ; et al. | 2009-05-28 |
| Heterocyclic Compounds And Uses Thereof App 20080300268 - SINGH; Juswinder ; et al. | 2008-12-04 |
| Pyrimidinylpyrazoles as Tgf-Beta Inhibitors App 20080171755 - Lee; Wen-Cherng ; et al. | 2008-07-17 |
| Structural interaction fingerprint App 20070134662 - Singh; Juswinder ; et al. | 2007-06-14 |
| Detecting protein similarity App 20070088506 - Singh; Juswinder ; et al. | 2007-04-19 |
| Structural interaction fingerprint App 20070020642 - Deng; Zhan ; et al. | 2007-01-25 |
| Pyrazoles and methods of making and using the same App 20060264440 - Lee; Wen-Cherng ; et al. | 2006-11-23 |
| Cell adhesion inhibitors App 20060166866 - Adams; Steven P. ; et al. | 2006-07-27 |
| Imidazolopyridines and methods of making and using the same App 20060135517 - Lee; Wen-Cherng ; et al. | 2006-06-22 |
| Pyrazolopyridines and methods of making and using the same App 20060106033 - Lee; Wen-Cherng ; et al. | 2006-05-18 |
| Cell adhesion inhibitors Grant 6,630,512 - Adams , et al. October 7, 2 | 2003-10-07 |
| Molecular model for VLA-4 inhibitors Grant 6,552,216 - Singh , et al. April 22, 2 | 2003-04-22 |
| Cell adhesion inhibitors App 20030018016 - Adams, Steven P. ; et al. | 2003-01-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 